Ketosis-Prone Type 2 Diabetes: A Case Series

被引：15

作者：

Sjoholm, Ake ^{[1
]}

机构：

[1] Gavle Cent Hosp, Dept Internal Med, Div Endocrinol & Diabetol, Gavle, Sweden

来源：

FRONTIERS IN ENDOCRINOLOGY | 2019年 / 10卷

关键词：

atypical diabetes; ketosis; Flatbush diabetes; GLP-1-glucagon-like peptide-1; SGLT; 2; inhibitor; BETA-CELL DYSFUNCTION; INSULIN-SECRETION; NORMOGLYCEMIC REMISSION; INTRAVENOUS GLUCOSE; ATYPICAL TYPE-1; KETOACIDOSIS; NIDDM; CLASSIFICATION; POPULATION; MECHANISM;

D O I：

10.3389/fendo.2019.00684

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Ketosis-prone type 2 diabetes ("Flatbush diabetes") carries features of both classical type 1 and type 2 diabetes and is highly prevalent in African populations. The disease, which is highly ketosis-prone, but neither chronically insulinopenic nor autoimmune, is discussed regarding pathogenesis, diagnosis and treatment from a patient case perspective.

引用

页数：7

共 49 条

[21] Genetics of diabetes - Are we missing the genes or the disease? [J].

Groop, Leif ;

Pociot, Flemming .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 382 (01) :726-739

[22] ANTIDIABETOGENIC EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE IN NORMAL SUBJECTS AND PATIENTS WITH DIABETES-MELLITUS [J].

GUTNIAK, M ;

ORSKOV, C ;

HOLST, JJ ;

AHREN, B ;

EFENDIC, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20) :1316-1322

[23] PANCREATIC BETA-CELLS ARE RENDERED GLUCOSE-COMPETENT BY THE INSULINOTROPIC HORMONE GLUCAGON-LIKE PEPTIDE-1(7-37) [J].

HOLZ, GG ;

KUHTREIBER, WM ;

HABENER, JF .

NATURE, 1993, 361 (6410) :362-365

[24] Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].

Kahn, Steven E. ;

Haffner, Steven M. ;

Heise, Mark A. ;

Herman, William H. ;

Holman, Rury R. ;

Jones, Nigel P. ;

Kravitz, Barbara G. ;

Lachin, John M. ;

O'Neill, M. Colleen ;

Zinman, Bernard ;

Viberti, Giancarlo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443

[25] The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes [J].

Karaa, Amel ;

Goldstein, Amy .

PEDIATRIC DIABETES, 2015, 16 (01) :1-9

[26] Editorial: Ketosis-prone diabetes - A new subgroup of patients with atypical type 1 and type 2 diabetes? [J].

Kitabchi, AE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5087-5089

[27] Mitochondrial diabetes - Molecular mechanisms and clinical presentation [J].

Maassen, JA ;

't Hart, LM ;

van Essen, E ;

Heine, RJ ;

Nijpels, G ;

Tafrechi, RSJ ;

Raap, AK ;

Janssen, GMC ;

Lemkes, HHPJ .

DIABETES, 2004, 53 :S103-S109

[28] Mitochondrial function in normal and diabetic β-cells [J].

Maechler, P ;

Wollheim, CB .

NATURE, 2001, 414 (6865) :807-812

[29] Sulfonylurea induced β-cell apoptosis in cultured human islets [J].

Maedler, K ;

Carr, RD ;

Bosco, D ;

Zuellig, RA ;

Berney, T ;

Donath, MY .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :501-506

[30] Ketosis-prone diabetes:: Dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes [J].

Maldonado, M ;

Hampe, CS ;

Gaur, LK ;

D'Amico, S ;

Iyer, D ;

Hammerle, LP ;

Bolgiano, D ;

Rodriguez, L ;

Rajan, A ;

Lernmark, Å ;

Balasubramanyam, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5090-5098

← 1 2 3 4 5 →